Deutsche Bank AG Has $21.69 Million Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Key Points

• Deutsche Bank AG reduced its stake in Option Care Health, Inc. by 2.6% during the first quarter, holding approximately 620,544 shares valued at $21.7 million.
• Several institutional investors, including Dimensional Fund Advisors and Northern Trust Corp, increased their holdings in Option Care Health, highlighting investor confidence in the company.
• Option Care Health reported a 15.4% year-over-year revenue growth, with earnings per share of $0.41 for the recent quarter, surpassing analysts' expectations.

Deutsche Bank AG decreased its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 2.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 620,544 shares of the company's stock after selling 16,761 shares during the quarter. Deutsche Bank AG owned 0.38% of Option Care Health worth $21,688,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Bessemer Group Inc. grew its position in shares of Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after acquiring an additional 599 shares in the last quarter. Public Employees Retirement System of Ohio grew its position in shares of Option Care Health by 21.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after acquiring an additional 332 shares in the last quarter. Wealthquest Corp acquired a new position in shares of Option Care Health in the 1st quarter worth approximately $66,000. Farther Finance Advisors LLC grew its position in shares of Option Care Health by 434.8% in the 1st quarter. Farther Finance Advisors LLC now owns 1,920 shares of the company's stock worth $67,000 after acquiring an additional 1,561 shares in the last quarter. Finally, Johnson Financial Group Inc. acquired a new position in shares of Option Care Health in the 4th quarter worth approximately $47,000. Institutional investors and hedge funds own 98.05% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. JMP Securities lifted their target price on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research report on Thursday, July 31st. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. Barrington Research reissued an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a report on Thursday, July 10th. Finally, Citigroup reissued an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. One analyst has rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Trading Down 0.3%

NASDAQ:OPCH traded down $0.09 during trading hours on Friday, hitting $28.32. 1,179,882 shares of the stock were exchanged, compared to its average volume of 1,593,526. The company's 50 day moving average is $30.29 and its two-hundred day moving average is $31.85. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. The company has a market capitalization of $4.60 billion, a P/E ratio of 22.66, a price-to-earnings-growth ratio of 1.80 and a beta of 0.79. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.40 by $0.01. The business had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The firm's revenue was up 15.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.30 EPS. On average, sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.